Apollo Endosurgery Inc.

6.08+0.4500+7.99%Vol 134.17K1Y Perf 162.72%
Apr 19th, 2021 11:51 DELAYED
BID6.06 ASK6.10
Open5.72 Previous Close5.63
Pre-Market- After-Market-
 - -%  - -
Target Price
8.00 
Analyst Rating
Hold 3.00
Potential %
34.00 
Finscreener Ranking
     42.46
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
     39.91
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
+     31.42
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Market Cap157.98M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
71.98 
Earnings Date
3rd May 2021

Today's Price Range

5.606.14

52W Range

1.257.96

5 Year PE Ratio Range

-1.40-0.2000

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-0.53%
1 Month
-9.49%
3 Months
44.36%
6 Months
222.64%
1 Year
162.72%
3 Years
-3.26%
5 Years
-66.77%
10 Years
-99.02%

TickerPriceChg.Chg.%
APEN6.080.45007.99
AAPL134.540.38000.28
GOOG2 299.862.10000.09
MSFT259.42-1.3200-0.51
XOM56.35-0.3100-0.55
WFC44.110.27000.62
JNJ162.580.34000.21
FB303.21-2.9700-0.97
GE13.35-0.0400-0.30
JPM153.23-0.0700-0.05
Financial StrengthValueIndustryS&P 500US Markets
3.80
5.00
0.89
8.58
-3.30
Leverage Ratio -30.10
ProfitabilityValueIndustryS&P 500US Markets
52.90
-40.90
-32.10
-57.30
-37.27
RevenueValueIndustryS&P 500US Markets
31.33M
1.21
-14.06
71.39
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.21-0.1433.33
Q03 2020-0.17-0.1135.29
Q02 2020-0.23-0.30-30.43
Q01 2020-0.49-0.490.00
Q04 2019--0.34-
Q03 2019-0.38-0.40-5.26
Q02 2019-0.35-0.40-14.29
Q01 2019-0.37-0.39-5.41
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.190.00-
6/2021 QR-0.160.00-
12/2021 FY-0.66-3.13Negative
12/2022 FY-0.48-6.67Negative
Next Report Date3rd May 2021
Estimated EPS Next Report-0.19
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume134.17K
Shares Outstanding25.98M
Trades Count765
Dollar Volume1.34M
Avg. Volume797.56K
Avg. Weekly Volume206.69K
Avg. Monthly Volume134.97K
Avg. Quarterly Volume927.89K

Apollo Endosurgery Inc. (NASDAQ: APEN) stock closed at 5.63 per share at the end of the most recent trading day (a -0.71% change compared to the prior day closing price) with a volume of 49.55K shares and market capitalization of 157.98M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 217 people. Apollo Endosurgery Inc. CEO is K. Todd Newton.

The one-year performance of Apollo Endosurgery Inc. stock is 162.72%, while year-to-date (YTD) performance is 65.59%. APEN stock has a five-year performance of -66.77%. Its 52-week range is between 1.25 and 7.96, which gives APEN stock a 52-week price range ratio of 71.98%

Apollo Endosurgery Inc. currently has a PE ratio of -5.50, a price-to-book (PB) ratio of 21.55, a price-to-sale (PS) ratio of 4.69, a price to cashflow ratio of 6.00, a PEG ratio of 2.32, a ROA of -28.51%, a ROC of -34.21% and a ROE of -499.01%. The company’s profit margin is -37.27%, its EBITDA margin is -32.10%, and its revenue ttm is $31.33 Million , which makes it $1.21 revenue per share.

Of the last four earnings reports from Apollo Endosurgery Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Apollo Endosurgery Inc.’s next earnings report date is 03rd May 2021.

The consensus rating of Wall Street analysts for Apollo Endosurgery Inc. is Hold (3), with a target price of $8, which is +34.00% compared to the current price. The earnings rating for Apollo Endosurgery Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apollo Endosurgery Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apollo Endosurgery Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 33.19, ATR14 : 0.59, CCI20 : 73.40, Chaikin Money Flow : 0.19, MACD : 0.25, Money Flow Index : 85.79, ROC : 4.07, RSI : 57.42, STOCH (14,3) : 84.93, STOCH RSI : 0.69, UO : 62.06, Williams %R : -15.07), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apollo Endosurgery Inc. in the last 12-months were: R. Kent McGaughy (Buy at a value of $2 225 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Strong Buy
1.00

Apollo Endosurgery Inc.

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focusses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include ORBERA, LAP-BAND and OverStitch.

CEO: K. Todd Newton

Telephone: +1 512 279-5100

Address: 1120 S. Capital of Texas Highway, Austin 78746, TX, US

Number of employees: 217

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

75%25%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

59%41%

News

Stocktwits